These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Emerging vectors and targeting methods for nonviral gene therapy. Lavigne MD; Górecki DC Expert Opin Emerg Drugs; 2006 Sep; 11(3):541-57. PubMed ID: 16939390 [TBL] [Abstract][Full Text] [Related]
4. Viral-mediated gene transfer for cancer treatment. Wilson DR Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258 [TBL] [Abstract][Full Text] [Related]
6. Invasive drug delivery. Blömer U; Ganser A; Scherr M Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831 [TBL] [Abstract][Full Text] [Related]
7. Virus vector design in gene therapy. Günzburg WH; Salmons B Mol Med Today; 1995 Dec; 1(9):410-7. PubMed ID: 9415189 [TBL] [Abstract][Full Text] [Related]
8. Artificial Virus as Trump-card to Resolve Exigencies in Targeted Gene Delivery. Ajithkumar KC; Pramod K Mini Rev Med Chem; 2018; 18(3):276-286. PubMed ID: 28552048 [TBL] [Abstract][Full Text] [Related]
9. Latest development in viral vectors for gene therapy. Lundstrom K Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368 [TBL] [Abstract][Full Text] [Related]
10. Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry. Ni R; Zhou J; Hossain N; Chau Y Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):3-26. PubMed ID: 27473931 [TBL] [Abstract][Full Text] [Related]
11. [Viral and nonviral gene therapy for treatment of retinal diseases]. Neidhardt J; Wycisk K; Klöckener-Gruissem B Ophthalmologe; 2005 Aug; 102(8):764-71. PubMed ID: 16012813 [TBL] [Abstract][Full Text] [Related]
12. Current status of gene delivery and gene therapy in lacrimal gland using viral vectors. Selvam S; Thomas PB; Hamm-Alvarez SF; Schechter JE; Stevenson D; Mircheff AK; Trousdale MD Adv Drug Deliv Rev; 2006 Nov; 58(11):1243-57. PubMed ID: 17056149 [TBL] [Abstract][Full Text] [Related]
13. Split vector systems for ultra-targeted gene delivery: a contrivance to achieve ethical assurance of somatic gene therapy in vivo. Tolmachov OE Med Hypotheses; 2014 Aug; 83(2):211-6. PubMed ID: 24854575 [TBL] [Abstract][Full Text] [Related]
14. Artificial viruses: exploiting viral trafficking for therapeutics. Glover DJ Infect Disord Drug Targets; 2012 Feb; 12(1):68-80. PubMed ID: 22034936 [TBL] [Abstract][Full Text] [Related]
15. Viral vectors for gene delivery and gene therapy within the endocrine system. Stone D; David A; Bolognani F; Lowenstein PR; Castro MG J Endocrinol; 2000 Feb; 164(2):103-18. PubMed ID: 10657846 [TBL] [Abstract][Full Text] [Related]
16. Versatility of gene therapy vectors through viruses. Barzon L; Stefani AL; Pacenti M; Palù G Expert Opin Biol Ther; 2005 May; 5(5):639-62. PubMed ID: 15934840 [TBL] [Abstract][Full Text] [Related]
17. Specific targets in tumor tissue for the delivery of therapeutic genes. Günther M; Wagner E; Ogris M Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):157-71. PubMed ID: 15777223 [TBL] [Abstract][Full Text] [Related]
18. Intrathecal Delivery of Viral Vectors for Gene Therapy. Kagiava A; Kleopa KA Methods Mol Biol; 2018; 1791():277-285. PubMed ID: 30006718 [TBL] [Abstract][Full Text] [Related]
19. Non-viral vectors in cancer gene therapy: principles and progress. Schatzlein AG Anticancer Drugs; 2001 Apr; 12(4):275-304. PubMed ID: 11335785 [TBL] [Abstract][Full Text] [Related]
20. Tumor vascular targeting therapy with viral vectors. Liu Y; Deisseroth A Blood; 2006 Apr; 107(8):3027-33. PubMed ID: 16373660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]